secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zeo ScientifiX, Inc. (ZEOX)
CIK:        0001557376
Form:       8-K
Filed at:   2025-07-09T23:59:59+00:00
Accession:  0001829126-25-004961
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ZEO ScientifiX launches expansion initiative following Florida's new stem cell law
--------------------------------------------------------------------------------

- Florida's SB-1768, effective July 1, 2025, authorizes non-FDA-approved stem cell therapies for defined conditions.
- ZEO launched a redesigned website (www.zeoscientifix.com) and partnered with Plus4 PR and Small Circle for brand growth.
- CEO Ian Bothwell expects additional states to follow, positioning ZEO to lead with its cGMP-compliant biologics platform.
- ZEO aims to set the industry standard via ethically sourced biologics, physician education, and compliant product inventory.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1557376/000182912625004961/0001829126-25-004961-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1557376/000182912625004961/zeoscientifix_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-25-004961

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer